Literature DB >> 21812486

Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from α-dystroglycan.

Kai-For Mo1, Tao Fang, Stephanie H Stalnaker, Pamela S Kirby, Mian Liu, Lance Wells, Michael Pierce, David H Live, Geert-Jan Boons.   

Abstract

Aberrant glycosylation of α-dystroglycan (α-DG) results in loss of interactions with the extracellular matrix and is central to the pathogenesis of several disorders. To examine protein glycosylation of α-DG, a facile synthetic approach has been developed for the preparation of unusual phosphorylated O-mannosyl glycopeptides derived from α-DG by a strategy in which properly protected phospho-mannosides are coupled with a Fmoc protected threonine derivative, followed by the use of the resulting derivatives in automated solid-phase glycopeptide synthesis using hyper-acid-sensitive Sieber amide resin. Synthetic efforts also provided a reduced phospho-trisaccharide, and the NMR data of this derivative confirmed the proper structural assignment of the unusual phospho-glycan structure. The glycopeptides made it possible to explore factors that regulate the elaboration of critical glycans. It was established that a glycopeptide having a 6-phospho-O-mannosyl residue is not an acceptor for action by the enzyme POMGnT1, which attaches β(1,2)-GlcNAc to O-mannosyl moietes, whereas the unphosphorylated derivate was readily extended by the enzyme. This finding implies a specific sequence of events in determining the structural fate of the O-glycan. It has also been found that the activity of POMGnT1 is dependent on the location of the acceptor site in the context of the underlying polypeptide/glycopeptide sequence. Conformational analysis by NMR has shown that the O-mannosyl modification does not exert major conformational effect on the peptide backbone. It is, however, proposed that these residues, introduced at the early stages of glycoprotein glycosylation, have an ability to regulate the loci of subsequent O-GalNAc additions, which do exert conformational effects. The studies show that through access to discrete glycopeptide structures, it is possible to reveal complex regulation of O-glycan processing on α-DG that has significant implications both for its normal post-translational maturation, and the mechanisms of the pathologies associated with hypoglycosylated α-DG.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812486      PMCID: PMC3176502          DOI: 10.1021/ja205473q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  31 in total

1.  Mechanistic studies and methods to prevent aglycon transfer of thioglycosides.

Authors:  Zhitao Li; Jeffrey C Gildersleeve
Journal:  J Am Chem Soc       Date:  2006-09-06       Impact factor: 15.419

2.  Glycomic analyses of mouse models of congenital muscular dystrophy.

Authors:  Stephanie H Stalnaker; Kazuhiro Aoki; Jae-Min Lim; Mindy Porterfield; Mian Liu; Jakob S Satz; Sean Buskirk; Yufang Xiong; Peng Zhang; Kevin P Campbell; Huaiyu Hu; David Live; Michael Tiemeyer; Lance Wells
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

Review 3.  Glycopeptides as versatile tools for glycobiology.

Authors:  Therese Buskas; Sampat Ingale; Geert-Jan Boons
Journal:  Glycobiology       Date:  2006-05-04       Impact factor: 4.313

4.  High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis.

Authors:  W Chai; C T Yuen; H Kogelberg; R A Carruthers; R U Margolis; T Feizi; A M Lawson
Journal:  Eur J Biochem       Date:  1999-08

5.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.

Authors:  A Yoshida; K Kobayashi; H Manya; K Taniguchi; H Kano; M Mizuno; T Inazu; H Mitsuhashi; S Takahashi; M Takeuchi; R Herrmann; V Straub; B Talim; T Voit; H Topaloglu; T Toda; T Endo
Journal:  Dev Cell       Date:  2001-11       Impact factor: 12.270

6.  A chemically synthesized version of the insect antibacterial glycopeptide, diptericin, disrupts bacterial membrane integrity.

Authors:  K A Winans; D S King; V R Rao; C R Bertozzi
Journal:  Biochemistry       Date:  1999-09-07       Impact factor: 3.162

Review 7.  Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.

Authors:  Paul T Martin
Journal:  Glycobiology       Date:  2003-05-07       Impact factor: 4.313

Review 8.  Dystroglycan glycosylation and muscular dystrophy.

Authors:  Christopher J Moore; Jane E Hewitt
Journal:  Glycoconj J       Date:  2008-09-05       Impact factor: 2.916

9.  N-Acetylglucosaminyltransferase IX acts on the GlcNAc beta 1,2-Man alpha 1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan.

Authors:  Kei-ichiro Inamori; Takeshi Endo; Jianguo Gu; Ichiro Matsuo; Yukishige Ito; Shigeru Fujii; Hiroko Iwasaki; Hisashi Narimatsu; Eiji Miyoshi; Koichi Honke; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2003-11-14       Impact factor: 5.157

10.  Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.

Authors:  Daniel Beltrán-Valero de Bernabé; Kei-Ichiro Inamori; Takako Yoshida-Moriguchi; Christine J Weydert; Hollie A Harper; Tobias Willer; Michael D Henry; Kevin P Campbell
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

View more
  16 in total

1.  Chemoenzymatic Assembly of Mammalian O-Mannose Glycans.

Authors:  Caicai Meng; Aniruddha Sasmal; Yan Zhang; Tian Gao; Chang-Cheng Liu; Naazneen Khan; Ajit Varki; Fengshan Wang; Hongzhi Cao
Journal:  Angew Chem Int Ed Engl       Date:  2018-06-25       Impact factor: 15.336

2.  Induction of Antibodies Directed Against Branched Core O-Mannosyl Glycopeptides-Selectivity Complimentary to the ConA Lectin.

Authors:  Sabine Stahl; Jin Yu; Oliver C Grant; Christian Pett; S Strahl; Robert J Woods; Ulrika Westerlind
Journal:  Chemistry       Date:  2017-02-16       Impact factor: 5.236

3.  Stereoselective assembly of complex oligosaccharides using anomeric sulfonium ions as glycosyl donors.

Authors:  Tao Fang; Kai-For Mo; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2012-04-18       Impact factor: 15.419

Review 4.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

5.  Chemoenzymatic synthesis of α-dystroglycan core M1 O-mannose glycans.

Authors:  Yan Zhang; Caicai Meng; Lan Jin; Xi Chen; Fengshan Wang; Hongzhi Cao
Journal:  Chem Commun (Camb)       Date:  2015-06-23       Impact factor: 6.222

6.  Mechanism of Glycosylation of Anomeric Sulfonium Ions.

Authors:  Tao Fang; Yi Gu; Wei Huang; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2016-02-29       Impact factor: 15.419

Review 7.  Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy.

Authors:  David Live; Lance Wells; Geert-Jan Boons
Journal:  Chembiochem       Date:  2013-11-07       Impact factor: 3.164

8.  Protein O-Linked Mannose β-1,4-N-Acetylglucosaminyl-transferase 2 (POMGNT2) Is a Gatekeeper Enzyme for Functional Glycosylation of α-Dystroglycan.

Authors:  Stephanie M Halmo; Danish Singh; Sneha Patel; Shuo Wang; Melanie Edlin; Geert-Jan Boons; Kelley W Moremen; David Live; Lance Wells
Journal:  J Biol Chem       Date:  2016-12-08       Impact factor: 5.157

9.  Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.

Authors:  Duy T Tran; Jae-Min Lim; Mian Liu; Stephanie H Stalnaker; Lance Wells; Kelly G Ten Hagen; David Live
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 10.  O-Mannosylation and human disease.

Authors:  Christina M Dobson; Samuel J Hempel; Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Cell Mol Life Sci       Date:  2012-11-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.